Interest in 3D bioprinting has been gaining momentum in recent years

Very exciting to observe that, Interest in 3D bioprinting has been gaining momentum in recent years, both in the academic and commercial settings.

According to Research and Markets, between 2014 and 2015, the market welcomed numerous 3D bioprinting companies, and new start-ups, spin-outs, and subsidiaries are continuing to emerge.

The futuristic goal of providing solutions for regenerative; fabricating organs for transplant is fueling key excitements.

Given certain market trends, analysts forecast that the global market for 3D bioprinting will reach a value of $1.8 billion by the year 2027.

3D bioprinting can be defined in a variety of ways. For example, 3D bioprinting as the deposition of living cells in a spatially controlled manner in the absence of any pre-existing scaffold and in more than a single layer.